About Index Trending news
Lists
Pricing
immuneXcite

immuneXcite

immuneXcite

Biopharmaceuticals ImmuneXcite is a biopharmaceutical company focused on developing the next generation of monoclonal antibodies for cancer, employing....

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding
Employees

Unknown size

Locations
HQ
Headquarters
$8,600,000 Venture capital (Series A)
FierceBiotech , ImmuneXcite

Sanofi Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round

Health Funding
$8,600,000 Venture capital (Series A)
FinSMEs , Xconomy

ImmuneXcite Completes $8.6M Series A-1 Financing

Health Funding